Showing 1 - 18 results of 18 for search 'Stefan O Schönland', query time: 0.05s
Refine Results
-
1
Treatment in AL Amyloidosis: Moving towards Individualized and Clone-Directed Therapy by Ute Hegenbart, Marc S. Raab, Stefan O. Schönland
Published 2021-12-01
Article -
2
-
3
-
4
CD4+CD25highCD127low Regulatory T Cells in Peripheral Blood Are Not an Independent Factor for Chronic Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation by Jolanta B. Perz, Selma Gürel, Stefan O. Schonland, Ute Hegenbart, Anthony D. Ho, Peter Dreger
Published 2012-01-01
Article -
5
Analysis of the complete lambda light chain germline usage in patients with AL amyloidosis and dominant heart or kidney involvement. by Natalie Berghaus, Sarah Schreiner, Martin Granzow, Carsten Müller-Tidow, Ute Hegenbart, Stefan O Schönland, Stefanie Huhn
Published 2022-01-01
Article -
6
Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis by Maximilian Steinebrei, Julian Baur, Anaviggha Pradhan, Niklas Kupfer, Sebastian Wiese, Ute Hegenbart, Stefan O. Schönland, Matthias Schmidt, Marcus Fändrich
Published 2023-11-01
Article -
7
Seroconversion Rates After the Second COVID-19 Vaccination in Patients With Systemic Light Chain (AL) amyloidosis by Nora Liebers, Stefan O. Schönland, Claudius Speer, Dominic Edelmann, Paul Schnitzler, Hans-Georg Kräusslich, Carsten Mueller-Tidow, Ute Hegenbart, Sascha Dietrich
Published 2022-03-01
Article -
8
Novel recurrent chromosomal aberrations detected in clonal plasma cells of light chain amyloidosis patients show potential adverse prognostic effect: first results from a genome-wi... by Martin Granzow, Ute Hegenbart, Katrin Hinderhofer, Dirk Hose, Anja Seckinger, Tilmann Bochtler, Kari Hemminki, Hartmut Goldschmidt, Stefan O. Schönland, Anna Jauch
Published 2017-07-01
Article -
9
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis by Tilmann Bochtler, Ute Hegenbart, Christiane Heiss, Axel Benner, Friedrich Cremer, Martin Volkmann, Jochen Ludwig, Jolanta B. Perz, Anthony D. Ho, Hartmut Goldschmidt, Stefan O. Schonland
Published 2008-03-01
Article -
10
Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis by Sara Karimi-Farsijani, Peter Benedikt Pfeiffer, Sambhasan Banerjee, Julian Baur, Lukas Kuhn, Niklas Kupfer, Ute Hegenbart, Stefan O. Schönland, Sebastian Wiese, Christian Haupt, Matthias Schmidt, Marcus Fändrich
Published 2024-06-01
Article -
11
Cryo-EM structure of a lysozyme-derived amyloid fibril from hereditary amyloidosis by Sara Karimi-Farsijani, Kartikay Sharma, Marijana Ugrina, Lukas Kuhn, Peter Benedikt Pfeiffer, Christian Haupt, Sebastian Wiese, Ute Hegenbart, Stefan O. Schönland, Nadine Schwierz, Matthias Schmidt, Marcus Fändrich
Published 2024-11-01
Article -
12
Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia by Tobias Dittrich, Axel Benner, Christoph Kimmich, Fabian aus dem Siepen, Kaya Veelken, Arnt V. Kristen, Tilmann Bochtler, Hugo A. Katus, Carsten Müller-Tidow, Ute Hegenbart, Stefan O. Schönland
Published 2019-07-01
Article -
13
Concurrent light chain amyloidosis and proximal tubulopathy: Insights into different aggregation behavior—A case report by Simone Feurstein, Julian Zoller, Constantin Schwab, Sarah Schreiner, Heiko Mundt, Iris Breitkreutz, Brigitte Schneider, Jörg Beimler, Martin Zeier, Rüdiger Waldherr, Stefan Gröschel, Carsten Müller‐Tidow, Stefan O. Schönland, Ute Hegenbart
Published 2022-11-01
Article -
14
HOVON 104, long‐term follow‐up of bortezomib‐dexamethasone induction therapy followed by autologous stem cell transplantation in newly diagnosed AL amyloidosis patients by Monique C. Minnema, Kazem Nasserinejad, Ute Hegenbart, Paula F. Ypma, Ka Lung Wu, Marie Jose Kersten, Sandra Croockewit, Sonja Zweegman, Lidwine Tick, Annemiek Broijl, Harry Koene, Gerard M. J. Bos, Pieter Sonneveld, Stefan O. Schönland
Published 2024-08-01
Article -
15
Lenalidomide/melphalan/dexamethasone in newly diagnosed patients with immunoglobulin light chain amyloidosis: results of a prospective phase 2 study with long-term follow up by Ute Hegenbart, Tilmann Bochtler, Axel Benner, Natalia Becker, Christoph Kimmich, Arnt V. Kristen, Jörg Beimler, Ernst Hund, Markus Zorn, Anja Freiberger, Marianne Gawlik, Hartmut Goldschmidt, Dirk Hose, Anna Jauch, Anthony D. Ho, Stefan O. Schönland
Published 2017-08-01
Article -
16
Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma by Gösta Gahrton, Simona Iacobelli, Giuseppe Bandini, Bo Björkstrand, Paolo Corradini, Charles Crawley, Ute Hegenbart, Gareth Morgan, Nicolaus Kröger, Anton Schattenberg, Stefan O. Schönland, Leo F. Verdonck, Lisa Volin, Theo de Witte, Dietger Niederwieser, the Myeloma Subcommittee of the EBMT
Published 2007-11-01
Article -
17
Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts by Iman Meziane, Stefanie Huhn, Miguel Inacio da Silva Filho, Niels Weinhold, Chiara Campo, Jolanta Nickel, Per Hoffmann, Markus M. Nöthen, Karl-Heinz Jöckel, Stefano Landi, Jonathan S. Mitchell, David Johnson, Anna Jauch, Gareth J. Morgan, Richard Houlston, Hartmut Goldschmidt, Paolo Milani, Giampaolo Merlini, Dorota Rowcieno, Philip Hawkins, Ute Hegenbart, Giovanni Palladini, Ashutosh Wechalekar, Asta Försti, Stefan O. Schönland, Kari Hemminki
Published 2017-10-01
Article -
18
Melphalan 140 mg/m2 or 200 mg/m2 for autologous transplantation in myeloma: results from the Collaboration to Collect Autologous Transplant Outcomes in Lymphoma and Myeloma (CALM)... by Holger W. Auner, Simona Iacobelli, Giulia Sbianchi, Cora Knol-Bout, Didier Blaise, Nigel H. Russell, Jane F. Apperley, David Pohlreich, Paul V. Browne, Guido Kobbe, Cecilia Isaksson, Stig Lenhoff, Christof Scheid, Cyrille Touzeau, Esa Jantunen, Achilles Anagnostopoulos, Ibrahim Yakoub-Agha, Alina Tanase, Nicolaas Schaap, Wieslaw Wiktor-Jedrzejczak, Marta Krejci, Stefan O. Schönland, Curly Morris, Laurent Garderet, Nicolaus Kröger
Published 2018-03-01
Article